G&L Scientific Inc. reveals that new offices will be located in Basel, Switzerland

Following the 2014 sale of their former company, Pharmalink Consulting, G&L Scientific was founded by industry veterans Peter Griffin and Stephen Loughrey. G&L has since undergone rapid growth as well as grown into every major geography to become one of the most respected scientific consultancies.
Basel, 2 October 2019 G&L Scientific Inc., a leading industry, international, scientific company with more than 25 years at the frontline of regulatory affairs as well as quality assurance, reported the opening of new offices in Basel, Switzerland.
The organization cites increased demand from Continental Europe customers as the catalyst for this latest expansion.
The opening of these additional offices in Switzerland, CEO Stephen Loughrey said, reaffirms G&L’s commitment to both existing and new customers in Europe — a key strategic focus area. It will allow them to provide all the strengths of global regulatory affairs as well as quality assurance consultancy to new and emerging companies, combined with local market expertise.
Mr. Loughrey added that they look forward to this expansion as well as the opportunity to serve their customers in Europe better as they expand and improve their presence in this important market.
About G&L Scientific:
G&L is a market-leading, multi-national, research consultancy that has been at the forefront of regulatory affairs including quality assurance for more than 25 years. G&L’s sectors include pharmaceuticals, genetics, medical devices, public safety, animal health, and generics.
G&L’s partnership models include operational products, outsourcing of portfolios, strategic advice and the provision of contingent capital.
The business has a major international presence with numerous worldwide offices and a large international consulting base. It has proven expertise in providing solutions to all kinds of scientific assignments, regardless of volume, place or time scale. G&L focuses exclusively on regulatory issues and quality assurance.